Bruker, headquartered in Billerica, Massachusetts, develops and distributes high-performance scientific instruments and solutions, employing 9,707 staff since its IPO in 2000. Key segments include BSI BioSpin, BSI CALID, BSI Nano, and BEST.
BRKR has been in the news recently: Bruker shares experienced a 12% decline after the company provided weak guidance, projecting earnings of 32-34 cents per share and revenue between $795 million and $798 million for Q3 2023. This decline occurred despite a broader positive trend in the market, where strong earnings reports contributed to record highs for the S&P 500 and Nasdaq 100.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
